Early adopters of ambient AI have seen promising early results from their pilots.
Nourish connects patients to registered dietitians on its telehealth platform.
A tumultuous stock market, threats of tariffs and reimbursement uncertainty have impeded what was supposed to be an active year for M&A in digital health.
FDA clearance would allow Medtronic to integrate the device with Abbott's continuous glucose monitoring sensor, advancing the companies' partnership.
Eli Lilly is trying to stop companies from selling compounded tirzepatide.
Waystar CEO Matt Hawkins said revenue cycle management tasks represent a ripe opportunity for generative AI.
The financing will help the company take the next step toward Food and Drug Administration approval.
Several providers are investing in the technology to improve patient care and manage costs.
There is an urgent need among payers and providers for guidance.
High-volume hemodiafiltration, used in Europe for more than a decade, took time to reach the U.S. due to limited research and design challenges.
A Medicare navigation company with ties to a pair of prominent conservatives reached unicorn status with a funding round announced Wednesday.
Epic’s development strategy for the tool closely resembles its blueprint for working with vendors in other areas.
The company said it expects up to $1.5 million in losses this quarter, in part due to legal costs from its dispute with the DOJ.
The company, co-founded by former GOP presidential candidate Vivek Ramaswamy, helps consumers pick Medicare and Medicare Advantage plans.